Precision Medicine and Progress in the Treatment of Hutchinson-Gilford Progeria Syndrome

doi:10.1001/jama.2018.2199

Editorial

. 2018 Apr 24;319(16):1663-1664.

doi: 10.1001/jama.2018.2199.

Precision Medicine and Progress in the Treatment of Hutchinson-Gilford Progeria Syndrome

Fuki Marie Hisama¹, Junko Oshima²

Affiliations

¹ Division of Medical Genetics, Department of Medicine, University of Washington, Seattle.
² Department of Pathology, University of Washington, Seattle.

PMID: 29710145
PMCID: PMC6368062
DOI: 10.1001/jama.2018.2199

Editorial

Precision Medicine and Progress in the Treatment of Hutchinson-Gilford Progeria Syndrome

Fuki Marie Hisama et al. JAMA. 2018.

. 2018 Apr 24;319(16):1663-1664.

doi: 10.1001/jama.2018.2199.

Authors

Fuki Marie Hisama¹, Junko Oshima²

Affiliations

¹ Division of Medical Genetics, Department of Medicine, University of Washington, Seattle.
² Department of Pathology, University of Washington, Seattle.

PMID: 29710145
PMCID: PMC6368062
DOI: 10.1001/jama.2018.2199

No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none were reported.

Comment on

Association of Lonafarnib Treatment vs No Treatment With Mortality Rate in Patients With Hutchinson-Gilford Progeria Syndrome.
Gordon LB, Shappell H, Massaro J, D'Agostino RB Sr, Brazier J, Campbell SE, Kleinman ME, Kieran MW. Gordon LB, et al. JAMA. 2018 Apr 24;319(16):1687-1695. doi: 10.1001/jama.2018.3264. JAMA. 2018. PMID: 29710166 Free PMC article.

References

1. Merideth MA, Gordon LB, Clauss S, et al. Phenotype and course of Hutchinson-Gilford progeria syndrome. N Engl J Med. 2008;358(6): 592–604. - PMC - PubMed
1. Gordon LB, Massaro J, D’Agostino RBSr, et al.; Progeria Clinical Trials Collaborative. Impact of farnesylation inhibitors on survival in Hutchinson-Gilford progeria syndrome. Circulation. 2014;130(1):27–34. - PMC - PubMed
1. Hutchinson J Congenital absence of hair and mammary glands with atrophic condition of the skin and its appendages, in a boy whose mother had been almost wholly bald from alopecia areata from the age of six. Med Chir Trans. 1886;69:473–477. - PMC - PubMed
1. Gilford H Ateleiosis and progeria: continuous youth and premature old age. BMJ. 1904;1904:914–918.
1. Eriksson M, Brown WT, Gordon LB, et al. Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature. 2003;423(6937):293–298. - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

Grants and funding

R01 CA210916/CA/NCI NIH HHS/United States

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations

[1] Merideth MA, Gordon LB, Clauss S, et al. Phenotype and course of Hutchinson-Gilford progeria syndrome. N Engl J Med. 2008;358(6): 592–604. - PMC - PubMed

[2] Merideth MA, Gordon LB, Clauss S, et al. Phenotype and course of Hutchinson-Gilford progeria syndrome. N Engl J Med. 2008;358(6): 592–604. - PMC - PubMed

[3] Gordon LB, Massaro J, D’Agostino RBSr, et al.; Progeria Clinical Trials Collaborative. Impact of farnesylation inhibitors on survival in Hutchinson-Gilford progeria syndrome. Circulation. 2014;130(1):27–34. - PMC - PubMed

[4] Gordon LB, Massaro J, D’Agostino RBSr, et al.; Progeria Clinical Trials Collaborative. Impact of farnesylation inhibitors on survival in Hutchinson-Gilford progeria syndrome. Circulation. 2014;130(1):27–34. - PMC - PubMed

[5] Hutchinson J Congenital absence of hair and mammary glands with atrophic condition of the skin and its appendages, in a boy whose mother had been almost wholly bald from alopecia areata from the age of six. Med Chir Trans. 1886;69:473–477. - PMC - PubMed

[6] Hutchinson J Congenital absence of hair and mammary glands with atrophic condition of the skin and its appendages, in a boy whose mother had been almost wholly bald from alopecia areata from the age of six. Med Chir Trans. 1886;69:473–477. - PMC - PubMed

[7] Gilford H Ateleiosis and progeria: continuous youth and premature old age. BMJ. 1904;1904:914–918.

[8] Gilford H Ateleiosis and progeria: continuous youth and premature old age. BMJ. 1904;1904:914–918.

[9] Eriksson M, Brown WT, Gordon LB, et al. Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature. 2003;423(6937):293–298. - PMC - PubMed

[10] Eriksson M, Brown WT, Gordon LB, et al. Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature. 2003;423(6937):293–298. - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Precision Medicine and Progress in the Treatment of Hutchinson-Gilford Progeria Syndrome

Affiliations

Precision Medicine and Progress in the Treatment of Hutchinson-Gilford Progeria Syndrome

Authors

Affiliations

Conflict of interest statement

Comment on

Similar articles

References

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources